Avalon GloboCare Corp. (NASDAQ:ALBT) Sees Significant Increase in Short Interest

Avalon GloboCare Corp. (NASDAQ:ALBT) was the target of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 114,200 shares, a growth of 275.7% from the November 30th total of 30,400 shares. Based on an average daily volume of 1,420,000 shares, the days-to-cover ratio is presently 0.1 days. Currently, 27.0% of the company’s stock are sold short.

Avalon GloboCare Price Performance

NASDAQ:ALBT opened at $3.29 on Friday. The firm has a 50-day moving average of $3.27 and a two-hundred day moving average of $4.42. The stock has a market cap of $3.60 million, a P/E ratio of -0.16 and a beta of 0.27. Avalon GloboCare has a 1-year low of $2.11 and a 1-year high of $21.60.

About Avalon GloboCare

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.